Cycle Pharma

Small molecule drug reformulation and repurposing for orphan indications

placeCambridge, England, United Kingdom calendar_todayFounded 2012 groups54 employees language cyclepharma.com

Registered entities

Social engagement

Social engagement: 19.9K social following, 7 posts in the last 12 months — around the industry typical range.

Investor mix

33 investors on record.

Investor typeCountShare
Venture capital13%
Other / undisclosed3297%

Recent activity

9 Jun 2026
Event
ASCO2026
4 Jun 2026
Event
Scientific Perspectives on Fumarate Transitions in MS: A Clinical Review of Monomethyl Fumarate (MMF) Data and Observations
2 Jun 2026
Product launch
Ph+ CML treatment option for Philadelphia chromosomepositive chronic myeloid leukemia
Coming soon